LIA
KMTS

Limestone Investment Advisors’s Kestra Medical Technologies KMTS Stock Holding History

Limestone Investment Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,712
Closed -$194K – 690
2025
Q2 		$194K Buy
+11,712
New +$256K 0.02% 387

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Limestone Investment Advisors's KMTS Position: Q3 2025 in Review

Limestone Investment Advisors sold out of Kestra Medical Technologies (KMTS) in Q3 2025, closing a stake of 11,712 shares — an estimated $194K sold.

Limestone Investment Advisors first reported a position in KMTS in Q2 2025 and held it in 1 quarter. The position peaked at $194K in Q2 2025. 80 funds tracked by Wall St. Rank hold KMTS as of Q3 2025.

  • Limestone Investment Advisors reported no remaining Kestra Medical Technologies position as of Q3 2025 after selling out during the quarter.
  • Limestone Investment Advisors sold 11,712 Kestra Medical Technologies shares in Q3 2025, an estimated $194K.
  • Limestone Investment Advisors first reported a position in Kestra Medical Technologies in Q2 2025 and held it in 1 quarter.
  • Limestone Investment Advisors's Kestra Medical Technologies position peaked at $194K in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2025.

Based on Limestone Investment Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.